Corporate Social Responsibility Report

Overview

The report describes the company's 2020 response to COVID-19 through expanded medicine and protective-material supply, donations exceeding RMB 20 million, and the Suikang mask-booking service. It highlights continued pharmaceutical R&D, including RMB 619 million in estimated R&D expenditure and new innovation platforms. Environmental disclosures include more than RMB 30 million of environmental-protection and energy-saving investment and detailed energy, water, emissions, and waste data. The report also records a workforce of 25,168 employees and 37.60 training hours per person.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services